BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 37082790)

  • 21. [Anti-p200 pemphigoid--a new bullous autoimmune dermatosis].
    Shimanovich I; Rose C; Hirako Y; Butt-Dörje E; Zillikens D
    J Dtsch Dermatol Ges; 2004 Jan; 2(1):7-14. PubMed ID: 16281877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
    Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
    Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
    Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States.
    Mascaró JM; Zillikens D; Giudice GJ; Caux F; Fleming MG; Katz HM; Diaz LA
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 2):309-15. PubMed ID: 10640922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid.
    Gao Y; Qian H; Hashimoto T; Li X
    Front Immunol; 2023; 14():1118846. PubMed ID: 36761755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmunity against laminin 332.
    Patzelt S; Schmidt E
    Front Immunol; 2023; 14():1250115. PubMed ID: 37638011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of Psoriasis and Bullous Diseases.
    Dainichi T; Kabashima K
    Front Med (Lausanne); 2018; 5():222. PubMed ID: 30135860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
    Kitayama S; Makino T; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
    J Dermatol; 2023 Sep; 50(9):1194-1198. PubMed ID: 37082790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-p200 pemphigoid.
    Goletz S; Hashimoto T; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-p200 pemphigoid].
    Holtsche MM; Goletz S; Zillikens D
    Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
    Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
    J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
    Yasuda H; Tomita Y; Shibaki A; Hashimoto T
    Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.